Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2010

01.05.2010 | Original Article

Non-invasive Testing for Helicobacter pylori in Patients Hospitalized with Peptic Ulcer Hemorrhage: A Cost-Effectiveness Analysis

verfasst von: Ashish Atreja, Alex Z. Fu, Madhusudan R. Sanaka, John J. Vargo

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Guidelines recommend routine invasive screening for Helicobacter pylori in patients with peptic ulcer hemorrhage (PUH). However, compliance with screening remains suboptimal. The aim of this study was to determine if a simplified approach based on noninvasive screening is cost effective in PUH.

Results

In the base case, post-endoscopy urea breath test (UBT) dominated the invasive testing with 34 fewer hemorrhages and cost savings of $406,600 in a cohort of 10,000 patients. When compliance with invasive testing decreases to 60%, post-endoscopy UBT leads to 109 fewer hemorrhages and cost savings of $1,089,600. The invasive strategy becomes the preferred choice if the sensitivity of UBT reduces to <75%, such as in patients taking proton-pump inhibitors (PPI) before hospitalization.

Conclusions

Post-endoscopy UBT is cost effective in PPI-naïve patients presenting with PUH. This strategy, once prospectively validated, can prove to be a preferred approach in institutions where compliance with invasive testing is suboptimal.
Literatur
1.
Zurück zum Zitat Gilbert DA. Epidemiology of upper gastrointestinal bleeding. Gastrointest Endosc. 1990;36:S8–S13.PubMed Gilbert DA. Epidemiology of upper gastrointestinal bleeding. Gastrointest Endosc. 1990;36:S8–S13.PubMed
3.
4.
Zurück zum Zitat Gisbert JP, Gonzalez L, de Pedro A, et al. Helicobacter pylori and bleeding duodenal ulcer: Prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol. 2001;36:717–724. doi:10.1080/003655201300191978.CrossRefPubMed Gisbert JP, Gonzalez L, de Pedro A, et al. Helicobacter pylori and bleeding duodenal ulcer: Prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol. 2001;36:717–724. doi:10.​1080/​0036552013001919​78.CrossRefPubMed
6.
Zurück zum Zitat Gisbert JP, Khorrami S, Carballo F, et al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev. 2004;2:CD004062.PubMed Gisbert JP, Khorrami S, Carballo F, et al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev. 2004;2:CD004062.PubMed
11.
12.
Zurück zum Zitat Colin R, Czernichow P, Baty V, et al. Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer. Gastroenterol Clin Biol. 2000;24:31–35.PubMed Colin R, Czernichow P, Baty V, et al. Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer. Gastroenterol Clin Biol. 2000;24:31–35.PubMed
17.
Zurück zum Zitat Henriksson AE, Edman AC, Held M, et al. Helicobacter pylori and acute bleeding peptic ulcer. Eur J Gastroenterol Hepatol. 1995;7:769–771.PubMed Henriksson AE, Edman AC, Held M, et al. Helicobacter pylori and acute bleeding peptic ulcer. Eur J Gastroenterol Hepatol. 1995;7:769–771.PubMed
18.
Zurück zum Zitat Kuyvenhoven JPH, Veenendaal RA, Vandenbroucke JP. Peptic ulcer bleeding: Interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system. Scand J Gastroenterol. 1999;34:1082–1086. doi:10.1080/003655299750024869.CrossRefPubMed Kuyvenhoven JPH, Veenendaal RA, Vandenbroucke JP. Peptic ulcer bleeding: Interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system. Scand J Gastroenterol. 1999;34:1082–1086. doi:10.​1080/​0036552997500248​69.CrossRefPubMed
23.
Zurück zum Zitat Thijs JC, van Zwet AA, Thijs WJ, et al. Diagnostic tests for Helicobacter pylori: A prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol. 1996;91:2125–2129.PubMed Thijs JC, van Zwet AA, Thijs WJ, et al. Diagnostic tests for Helicobacter pylori: A prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol. 1996;91:2125–2129.PubMed
26.
Zurück zum Zitat Ng TM, Fock KM, Ho J, et al. Clotest (rapid urease test) in the diagnosis of Helicobacter pylori infection. Singapore Med J. 1992;33:568–569.PubMed Ng TM, Fock KM, Ho J, et al. Clotest (rapid urease test) in the diagnosis of Helicobacter pylori infection. Singapore Med J. 1992;33:568–569.PubMed
27.
Zurück zum Zitat Loy C, Irwig L, Katelaris P, et al. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. Am J Gastroenterol. 1996;91:1138–1144.PubMed Loy C, Irwig L, Katelaris P, et al. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. Am J Gastroenterol. 1996;91:1138–1144.PubMed
30.
Zurück zum Zitat Moayyedi P, Carter AM, Catto A, et al. Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ. 1997;314:119.PubMed Moayyedi P, Carter AM, Catto A, et al. Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ. 1997;314:119.PubMed
31.
Zurück zum Zitat Kroser J, Faigel D, Furth E, et al. Comparison of rapid office based serology with formal laboratory-based testing for diagnosis of Helicobacter pylori gastritis. Dig Dis Sci. 1998;45:103–108. doi:10.1023/A:1018832306135.CrossRef Kroser J, Faigel D, Furth E, et al. Comparison of rapid office based serology with formal laboratory-based testing for diagnosis of Helicobacter pylori gastritis. Dig Dis Sci. 1998;45:103–108. doi:10.​1023/​A:​1018832306135.CrossRef
33.
34.
Zurück zum Zitat Stevens M, Livsey S, Swann R, et al. Evaluation of Sixteen EIAs for the Detection of Antibodies to Helicobacter pylori. London: Department of Health; 1997:1–46. Stevens M, Livsey S, Swann R, et al. Evaluation of Sixteen EIAs for the Detection of Antibodies to Helicobacter pylori. London: Department of Health; 1997:1–46.
35.
Zurück zum Zitat McNulty CA, Nair P, Watson B, et al. A comparison of six commercial kits for Helicobacter pylori detection. Commun Dis Public Health. 1999;2:59–63.PubMed McNulty CA, Nair P, Watson B, et al. A comparison of six commercial kits for Helicobacter pylori detection. Commun Dis Public Health. 1999;2:59–63.PubMed
37.
Zurück zum Zitat Conwell CF, Lyell R, Rodney WM. Prevalence of Helicobacter pylori in family practice patients with refractory dyspepsia: A comparison if tests available in the office. J Fam Pract. 1995;41:245–249.PubMed Conwell CF, Lyell R, Rodney WM. Prevalence of Helicobacter pylori in family practice patients with refractory dyspepsia: A comparison if tests available in the office. J Fam Pract. 1995;41:245–249.PubMed
40.
Zurück zum Zitat Santander C, Gravalos RG, Gomez-Cedenilla A, et al. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: Prospective nonrandomized trial on 125 patients. Am J Gastroenterol. 1996;91:1549–1552.PubMed Santander C, Gravalos RG, Gomez-Cedenilla A, et al. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: Prospective nonrandomized trial on 125 patients. Am J Gastroenterol. 1996;91:1549–1552.PubMed
41.
Zurück zum Zitat Lai KC, Hui WM, Wong WM, et al. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage—A long-term randomized, controlled study (in process citation). Am J Gastroenterol. 2000;95:2225–2232.PubMed Lai KC, Hui WM, Wong WM, et al. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage—A long-term randomized, controlled study (in process citation). Am J Gastroenterol. 2000;95:2225–2232.PubMed
45.
Zurück zum Zitat Winiarski M, Bielanski W, Plonka M, et al. The usefulness of capsulated 13C-urea breath test in diagnosis of Helicobacter pylori infection in patients with upper gastrointestinal bleeding. J Clin Gastroenterol. 2003;37:34–38. doi:10.1097/00004836-200307000-00010.CrossRefPubMed Winiarski M, Bielanski W, Plonka M, et al. The usefulness of capsulated 13C-urea breath test in diagnosis of Helicobacter pylori infection in patients with upper gastrointestinal bleeding. J Clin Gastroenterol. 2003;37:34–38. doi:10.​1097/​00004836-200307000-00010.CrossRefPubMed
48.
Zurück zum Zitat de Leest HTJI, Steen KSS, Lems WF, et al. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: Double-blind, randomized, placebo-controlled trial. Helicobacter. 2007;12(5):477–485. doi:10.1111/j.1523-5378.2007.00543.x.CrossRefPubMed de Leest HTJI, Steen KSS, Lems WF, et al. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: Double-blind, randomized, placebo-controlled trial. Helicobacter. 2007;12(5):477–485. doi:10.​1111/​j.​1523-5378.​2007.​00543.​x.CrossRefPubMed
Metadaten
Titel
Non-invasive Testing for Helicobacter pylori in Patients Hospitalized with Peptic Ulcer Hemorrhage: A Cost-Effectiveness Analysis
verfasst von
Ashish Atreja
Alex Z. Fu
Madhusudan R. Sanaka
John J. Vargo
Publikationsdatum
01.05.2010
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2010
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0865-6

Weitere Artikel der Ausgabe 5/2010

Digestive Diseases and Sciences 5/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.